Oral androgens in man-4: gonadotropin suppression medicated by oral testosterone enanthate in oil plus dutasteride (short title: Oral T-4)

Trial Profile

Oral androgens in man-4: gonadotropin suppression medicated by oral testosterone enanthate in oil plus dutasteride (short title: Oral T-4)

Completed
Phase of Trial: Phase I/II

Latest Information Update: 09 Dec 2015

At a glance

  • Drugs Dutasteride (Primary) ; Testosterone enanthate
  • Indications Alopecia; Benign prostatic hyperplasia; Hypogonadism; Prostate cancer; Prostatic intraepithelial neoplasia
  • Focus Pharmacodynamics
  • Acronyms ORAL-T-4
  • Most Recent Events

    • 01 Jun 2008 Results have been published in the Journal of Urology.
    • 02 Nov 2007 Status changed from in progress to completed.
    • 25 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top